Sponsored Feature: Small changes making a massive impact for McGee Pharma International
Published 14/11/2012 | 16:29
We caught up with regulatory compliance and training services firm McGee Pharma International at a recent SFA Business Bytes seminar, supported by Bord Gáis Energy, to discuss the company’s recent successes and the ambitious plans managing director, Ann McGee has for the business. Ann gave us a valuable insight into the challenges and opportunities she sees for her business and SMEs in general operating in this sector in the current economic climate.
“Innovation is the key to success.”
Ann McGee is managing director of McGee Pharma International, a professional services firm specialising in the provision of quality, compliance, technical support and tailored training for the pharmaceutical and medical device sectors worldwide.
The firm offers bespoke services including auditing, gap analysis, technical remediation solutions and personnel training.
“My key responsibility is to provide leadership and guidance to the team so that clients receive the quality and expertise that they expect and deserve. I am also responsible for identifying new opportunities. I have a clear vision for the company and my role is to empower my team to deliver on it,” explains Ann.
Ann has ambitious plans for the business in the coming year and her vision is that McGee Pharma International will be the GMP service provider of choice for the top 10 multinational pharmaceutical companies in Europe and the USA by 2015.
“Innovation is the key to success. Small changes can have a massive impact and in my view, no idea or suggestion is too small to research and review. You never know when the next opportunity will present itself. Educated risks will also pay dividends and are essential in business,” says Ann.
KEY CHALLENGES AND OPPORTUNITIES FOR 2013
“My plan for the coming year is to continue to introduce new services, expand our client base, build on client relationships and continue to provide a service with excellence and customer care at its core. This will involve opening a new office in the USA in the second half of 2013.”
In terms of growth areas, Ann sees a wealth of opportunity for the company in the pharmaceutical sector, which she says is ever changing with regulatory requirements constantly evolving
Speaking about the challenges facing the business, Ann believes a real challenge for McGee Pharma International is getting the right people on board.
“Our challenge is to recruit the right people with a scientific background and experience and with an attitude that matches the drive and ambition of a young and growing international business.”
SME BUSINESS CLIMATE
Assuming that a business is viable, however, Ann considers an economic recession to be a wonderful opportunity to invest in and grow a business.
“A recession should provide access to an experienced and talented workforce at a reasonable price, while offering that workforce new opportunities for personal and professional growth and development,” she says.
ENERGISING THE SME SECTOR
For the small business sector overall, Ann says, “the greatest challenge in the current economic climate is accessing finance to support the growth of international business.”
She would like to see tax breaks for employers to help generate funds for reinvestment in business growth.
“Access to broadband that supports international business is also absolutely essential if small businesses in Ireland are to compete on a global scale,” she concludes.
BUSINESS BYTES SEMINARS
McGee Pharma International presented an overview of their company at a recent SFA Business Bytes seminar supported by Bord Gáis Energy. Ann gives an account of what they took away from the free seminar entitled, Succession Planning – the time is now’;
“Taxation considerations are always vital when transferring a business to the next generation, especially at such a crucial time in its lifecycle. It was very beneficial to get an insight into some of the reliefs available and how to maximise tax efficiencies.”